3-(2-AMINO-4-PYRIMIDINYL)BENZENECARBONITRILE, 95.0%, 5g

(S)-Methyl 2-amino-3-(4-bromophenyl)propanoate hydrochloride, 95.0%, 1g

2-(3-Chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid, 98%, 500mg

5-Pyrazolone>98.0%(GC)1g

(R)-5-(HYDROXYMETHYL)-1-METHYLPYRROLIDIN-2-ONE, 95.0%, 100mg

GC capillary column ROTI®Cap-1, 60 m, 0.25 mm, 0.25 µm, 1 Piece(s)

3-(3,4-Dihydroxyphenyl)-2-oxopropanoic acid, 95.0%, 100mg

2,5,8,11,14,17,20,23,26,29,32,35,38-Tridecaoxahentetracontan-41-oic acid, 95%, 250mg

1,3-Dichloro-2-methoxybenzene, 95.0%, 100g

rac-(1R,2R)-2-methoxycyclopentanamine, 95.0%, 100mg

5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione; but-2-enedioic acid, 97.0%, 1g

4-(pyridin-2-ylmethoxy)benzaldehyde, 95.0%, 1g

Ranitidine Hydrochloride>98.0%(HPLC)(T)5g